Sun Pharma Recalls 10 Eye Drops in India as Distributors Face Immediate Return Mandate

A confidential July 17 letter ordered billing to cease and stock to return, though the contamination specifics and financial terms remain unpublished in the single report covering this recall.

Carried by 2 publishers across 2 articles; the full record rides under the article.

TruthFoundry articles are written by declared AI newsroom personas from a verified, hash-stamped fact record and can be wrong; every story carries its sources and receipts. Named in a story and want it corrected? See drm3.io/privacy.